|1.||Nebol'sin, V E: 13 articles (09/2012 - 01/2008)|
|2.||Kiselev, O I: 7 articles (05/2012 - 01/2010)|
|3.||Zarubaev, V V: 7 articles (05/2012 - 01/2010)|
|4.||Reĭkhart, D V: 5 articles (09/2012 - 09/2011)|
|5.||Kalinina, N A: 4 articles (09/2012 - 01/2010)|
|6.||Garshinina, A V: 4 articles (09/2012 - 01/2010)|
|7.||Beliaevskaia, S V: 4 articles (03/2012 - 01/2010)|
|8.||Sirotkin, A K: 3 articles (09/2012 - 09/2011)|
|9.||Merkulova, L N: 3 articles (01/2011 - 01/2009)|
|10.||Chuchalin, A G: 3 articles (01/2011 - 04/2010)|
|1.||Human Influenza (Influenza)
01/01/2009 - "Ingavirin is safe and effective in the treatment of influenza. "
01/01/2009 - "[Efficacy of ingavirin in adults with influenza]."
09/01/2011 - "The aim of this investigation was to study the effect of ingavirin on the structure and properties of influenza virions forming in its presence. "
05/01/2010 - "The cultured cells showed no significant antiviral activity of ingavirin at nontoxic concentrations (up to 200 microg/ml) against all study strains of influenza A and B viruses, including pandemic A(H1N1) influenza virus strains. "
01/01/2011 - "The data on the efficiency of Ingavirin, a new Russian antiviral for the treatment of influenza, are reported."
01/01/2009 - "[In vitro Ingavirin efficacy against adenoviral infection pathogen]."
01/01/2012 - "The experimental studies suggest that when added at a concentration of 50 to 500 microg/ml to a nutrient medium 24 hours after HMPV infection, Ingavirin suppressed effectively virus replication by 2.2-3.3 logs, respectively. "
01/01/2012 - "When used at a concentration of 500 microg/ml 24 hours before cell infection, Ingavirin protected cells from HMPV infection."
01/01/2012 - "The antiviral activity of Ingavirin against human metapneumovirus (HMPV) infection was investigated in vitro. "
01/01/2011 - "This finding gives reason to recommend Ingavirin for the wide clinical application as an agent for combined therapy of acute respiratory viral infections."
05/01/2010 - "The found efficacy of ingavirin on an integral model of murine influenza pneumonia without its activity in the cultured cells is likely to be due to other pharmacological properties of the drug rather than its direct virus-specific action."
03/01/2012 - "[Ingavirin treatment of experimental parainfluenza pneumonia in Syrian hamsters]."
04/01/2010 - "Clinical displays of influenza and influenzal pneumonia, and also main principles antiviral and antibacterial therapy with use Ingavirin are described."
05/01/2010 - "The activity of rimantadine, arbidol, and ingavirin was found on a model of Influenza pneumonia in mice infected with their adopted influenza A/Aichi/2/69(H3N2) virus. "
01/01/2011 - "[Efficacy of Ingavirin in the combined treatment of ARVI complicated by tonsillitis]."
01/01/2011 - "This paper was designed to report the results of an open randomized comparative study of therapeutic efficacy of Ingavirin used for the treatment of adult patients with acute respiratory viral infections (ARVI) complicated by lacunar tonsillitis. "
|5.||Hepatitis B Surface Antigens (HBsAg)
|6.||Antiviral Agents (Antivirals)